Edition:
India

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.47USD
16 Jan 2018
Change (% chg)

$-0.12 (-4.63%)
Prev Close
$2.59
Open
$2.61
Day's High
$2.61
Day's Low
$2.41
Volume
34,506
Avg. Vol
23,747
52-wk High
$7.15
52-wk Low
$2.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 40.47 0.385
Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
FY 2016 Dec '16 30.17 -8.908
Sep '16 41.47 -2.990
Jun '16 36.75 -4.669
Mar '16 32.47 -4.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.81 36.90
P/E High - Last 5 Yrs. -- 40.83 45.68
P/E Low - Last 5 Yrs. -- 23.55 24.26
Beta 1.69 0.89 0.88
Price to Sales (TTM) 0.22 4.04 6.58
Price to Book (MRQ) -- 4.89 5.79
Price to Tangible Book (MRQ) -- 5.78 7.43
Price to Cash Flow (TTM) -- 23.51 25.31
% Owned Institutions 20.92 1.12 1.86

Dividends

  Company industry sector
Dividend Yield -- 1.53 1.46
Dividend Yield - 5 Year Avg -- 2.16 2.03
Dividend 5 Year Growth Rate -- 4.33 5.32
Payout Ratio(TTM) -- 47.39 45.96

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -2.41 6.35 6.77
Sales (TTM) vs TTM 1 Yr. Ago -14.23 6.61 6.98
Sales - 5 Yr. Growth Rate 18.37 10.01 10.31
EPS (MRQ) vs Qtr. 1 Yr. Ago 112.88 7.07 7.71
EPS (TTM) vs TTM 1 Yr. Ago 46.05 -- --
EPS - 5 Yr. Growth Rate -- 10.04 11.11
Capital Spending - 5 Yr. Growth Rate 41.15 15.13 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.91 2.48 2.55
Current Ratio (MRQ) 0.99 3.49 3.56
LT Debt to Equity (MRQ) -- 11.43 13.94
Total Debt to Equity (MRQ) -- 17.67 20.02
Interest Coverage (TTM) -3.72 40.21 35.70

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 70.18 55.37 54.98
Gross Margin - 5 Yr. Avg. 64.57 52.53 52.60
EBITD Margin (TTM) 6.14 -- --
EBITD - 5 Yr. Avg -0.57 18.51 15.30
Operating Margin (TTM) -69.70 14.68 5.68
Operating Margin - 5 Yr. Avg. -56.18 14.28 10.55
Pre-Tax Margin (TTM) -96.70 15.12 6.55
Pre-Tax Margin - 5 Yr. Avg. -69.72 14.59 10.95
Net Profit Margin (TTM) -97.10 11.31 2.79
Net Profit Margin - 5 Yr. Avg. -65.04 10.93 7.23
Effective Tax Rate (TTM) -- 24.36 24.25
Effective Tax Rate - 5 Yr. Avg. -- 23.45 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 728,108 935,327,385 838,511,530
Net Income/Employee (TTM) -707,000 109,328,143 97,909,667
Receivable Turnover (TTM) 2.89 5.89 6.15
Inventory Turnover (TTM) 4.89 2.72 3.54
Asset Turnover (TTM) 0.44 0.99 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -42.48 11.78 11.22
Return on Assets - 5 Yr. Avg. -23.23 12.80 12.19
Return on Investment (TTM) -60.69 14.96 14.28
Return on Investment - 5 Yr. Avg. -31.36 16.75 15.96
Return on Equity (TTM) -- 16.51 15.94
Return on Equity - 5 Yr. Avg. -138.91 17.80 17.22
  1 Year 3 Year 5 Year
Sales % -19.90 18.40 18.37
EPS (TTM) % 22.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 20.92%
# of Holders: 41
Total Shares Held: 2,412,803
3 Mo. Net Change: -1,267
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.